initial regimen
Showing 1 - 25 of >10,000
Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))
Recruiting
- Glioblastoma
- GBM
- XS005 Cell Injection
- Temozolomide（TMZ）
-
Suzhou, Jiangsu, ChinaDushu Lake Hospital Affiliated to Soochow University
Nov 23, 2023
Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))
Active, not recruiting
- Metastatic Colorectal Cancer
- Aflibercept
- +4 more
-
Madrid, SpainSpanish Cooperative Group for Digestive Tumour Therapy (TTD)
Oct 10, 2022
Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Guangzhou (CSII with formula-based initial insulin regimen,
Recruiting
- Diabetes Mellitus
- +4 more
- CSII with formula-based initial insulin regimen
- CSII with weight-based initial insulin regimen
-
Guangzhou, Guangdong, Chinaendocrinology department of the first affiliated hospital of Sun
Oct 8, 2021
Tuberculosis, HIV-1-infection, Immuno-Deficiency Trial in Worldwide (Intensified TB treatment (initial phase), WHO standard TB
Recruiting
- Tuberculosis
- +2 more
- Intensified TB treatment (initial phase)
- WHO standard TB treatment (initial phase)
-
Phnom Penh, Cambodia
- +5 more
May 3, 2022
Gallbladder Cancer, Initially Unresectable, the First Line Treatment Trial in Shanghai (Combination of Gemcitabine,
Recruiting
- Gallbladder Cancer
- +2 more
- Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 24, 2023
Esophageal Squamous Cell Carcinomas Trial (PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1
Not yet recruiting
- Esophageal Squamous Cell Carcinomas
- PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
- (no location specified)
Nov 1, 2021
HIV-1 Infection Trial in Yaoundé (Dolutegravir 50 mg, Tenofovir disoproxil fumarate 300 mg / lamivudine 300 mg, Efavirenz 400
Completed
- HIV-1 Infection
- Dolutegravir 50 mg
- +2 more
-
Yaoundé, Cameroon
- +2 more
Aug 26, 2021
Follicular Lymphoma Trial in Italy (Immunochemo regimen: Rituximab-bendamustine (Arm A), Immunochemo regimen:
Recruiting
- Follicular Lymphoma
- Immunochemotherapy regimen: Rituximab-bendamustine (Arm A)
- +9 more
-
Barletta, Barletta Andria Trani, Italy
- +68 more
Oct 13, 2022
Pathologic Myopia Trial in Lutsk, Mykolaiv, Odesa (Intravitreal injection)
Recruiting
- Pathologic Myopia
- Intravitreal injection
-
Lutsk, Ukraine
- +3 more
Mar 23, 2022
Dexmedetomidine, Mechanical Ventilation Complication, Critically Ill Trial in United States (Fentanyl, Dexmedetomidine)
Terminated
- Dexmedetomidine
- +2 more
-
Little Rock, Arkansas
- +18 more
Oct 7, 2021
HIV Trial in United States (Indinavir sulfate, Ritonavir, Nelfinavir mesylate)
Completed
- HIV Infections
- Indinavir sulfate
- +3 more
-
San Francisco, California
- +14 more
Oct 27, 2021
Low-dose Vonoprazan for Helicobacter Pylori Eradication
Not yet recruiting
- Helicobacter Pylori Infection
- (no location specified)
Sep 7, 2023
Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)
Recruiting
- Newly Diagnosed Peripheral T-cell Lymphoma
-
Nanjing, Jiangsu, ChinaHematological Department, People's Hospital of Jiangsu Province
Jun 1, 2023
Status Epilepticus Trial in Albuquerque, Cincinnati, Columbus (IV Ganaxolone, IV Placebo)
Not yet recruiting
- Status Epilepticus
- IV Ganaxolone
- IV Placebo
-
Albuquerque, New Mexico
- +2 more
Mar 8, 2023
Breast Cancer Female, Breast Tumor Female Trial in United States (SV-BR-1-GM, INCMGA00012, Low dose cyclophosphamide)
Recruiting
- Breast Cancer
- +3 more
- SV-BR-1-GM
- +3 more
-
Newport Beach, California
- +9 more
Dec 8, 2022
Pilonidal Disease Trial in Palo Alto (Regular Epilation Regimen, Surgical excision)
Not yet recruiting
- Pilonidal Disease
- Regular Epilation Regimen
- Surgical excision
-
Palo Alto, CaliforniaStanford University School of Medicine
Jun 27, 2022
Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)
Recruiting
- Ototoxicity, Drug-Induced
- Sodium Thiosulfate
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Mar 6, 2023
Waldenström's Macroglobulinemia Trial (zanubrutinib,bendamustine,rituximab)
Not yet recruiting
- Waldenström's Macroglobulinemia
- (no location specified)
Aug 4, 2023
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet
Recruiting
- Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
- statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
-
Beijing, Beijing, ChinaPeking University People's Hospital
Oct 22, 2023
Mantle Cell Lymphoma Trial in Beijing
Recruiting
- Mantle Cell Lymphoma
-
Beijing, Beijing, ChinaHongmei Third Jing
Jun 20, 2022
Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon
Not yet recruiting
- Breast Cancer
- +4 more
- SV-BR-1-GM
- +4 more
-
Port Jefferson Station, New YorkNew York Cancers & Blood Specialists
Oct 2, 2023
Gastric Cancer, Chemo Effect, Immune Checkpoint Inhibitor Trial in Shanghai (Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU)
Recruiting
- Gastric Cancer
- +2 more
- Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 1, 2023
Atrial Fibrillation Trial in Lexington (AMIODARONE)
Recruiting
- Atrial Fibrillation
-
Lexington, KentuckyUniversity of Kentucky Medical Center
Nov 17, 2022
Treatment Optimization of Refractory
Recruiting
- Hepatitis B, Chronic
- Virus Diseases
- original therapy
- rescue therapy
-
Ankang, China
- +12 more
Feb 1, 2023